Previous 10 | Next 10 |
2023-06-06 02:59:44 ET Summary AI development has potential to create job losses, new jobs, and enhance current jobs, with early winners, including Nvidia, Microsoft, and Alphabet. Downstream beneficiaries of AI include businesses that can reduce headcount or accelerate growth, su...
EXACT SCIENCES EARNS 2023 GREAT PLACE TO WORK® CERTIFICATION™ PR Newswire Award marks fifth consecutive year company has received prestigious distinction MADISON, Wis. , June 1, 2023 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a ...
Exact Sciences Presents New Long-Term Patient Outcomes in Multi-Cancer Early Detection and Breast Cancer Recurrence Testing at ASCO® 2023 PR Newswire Exact Sciences' approach in multi-cancer early detection (MCED) confirmed in first-ever, long-term, follow-up data from ...
2023-05-25 09:15:00 ET Growth stocks are all the rage this year, so it's little surprise that Cathie Wood's ARK Innovation exchange-traded fund has been doing well -- it's up 29%. Three of the hottest stocks within that fund are Tesla (NASDAQ: TSLA) , DraftKings (NASDAQ: D...
EXACT SCIENCES AWARDS GRANTS TO 18 ORGANIZATIONS FOCUSED ON INCREASING COLORECTAL CANCER SCREENINGS PR Newswire MADISON, Wis. , May 17, 2023 /PRNewswire/ -- Exact Sciences, a leading provider of cancer screening and diagnostic tests, announced today that it award...
2023-05-15 07:50:04 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Medicine is not always simple. A drug that cures one patient can easily kill another, based on anything from their weight to their genes to anything else. Because of that doctors must always be...
2023-05-11 14:58:26 ET Shares of Exact Sciences (NASDAQ: EXAS) stormed higher by 16.5% over the first three and a half days of trading this week, according to data provided by S&P Global Market Intelligence . The big gain came after the biotech posted better-than-expected fi...
2023-05-10 14:42:02 ET Shares of Exact Sciences Corporation (NASDAQ: EXAS) were up 11.5% on Wednesday afternoon, a day after the biotech company announced first-quarter earnings . The company, which specializes in cancer diagnostics , has seen its shares rise about 60% s...
2023-05-09 20:30:26 ET Image source: The Motley Fool. Exact Sciences (NASDAQ: EXAS) Q1 2023 Earnings Call May 09, 2023 , 5:00 p.m. ET Operator Continue reading For further details see: Exact Sciences (EXAS) Q1 2023 Earnings Call Transcript
2023-05-09 19:56:03 ET Exact Sciences Corporation (EXAS) Q1 2023 Earnings Conference Call May 9, 2023 05:00 PM ET Company Participants Megan Jones - IR Kevin Conroy - Chairman & CEO Jeffrey Elliott - CFO & COO Everett Cunningham - Chief Commercial Off...
News, Short Squeeze, Breakout and More Instantly...
Exact Sciences Corporation Company Name:
EXAS Stock Symbol:
NASDAQ Market:
Exact Sciences Corporation Website:
2024-07-11 08:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-08 08:30:00 ET To say that Exact Sciences (NASDAQ: EXAS) hasn't performed well on the stock market this year would be an understatement. Shares of the cancer-focused biotech are down by 41%. However, the healthcare company still has some fans on Wall Street. Cathie Wood ...
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its second quarter 2024 financial results after the close of the U.S. financial markets on July 31, 2024. Following the release, company management w...